Stay updated on Teriflunomide in Pediatric MS Clinical Trial
Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page
- Check3 days agoChange DetectedTel Litwinsky, Israel, 52621 was added as a participating site. Qiryat Krinitzi, Israel, 52621 was removed from the list of study locations.SummaryDifference0.1%

- Check10 days agoChange DetectedA new site in Qiryat Krinitzi, Israel (52621) was added and the Tel Litwinsky site (52621) was removed, changing the study’s geographic footprint and potentially affecting participant access in Israel.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a newer version of the page content.SummaryDifference0.0%

- Check39 days agoChange DetectedA new site revision label Revision: v3.6.5 was added, and several related topics links such as 'Multiple sclerosis' and 'MedlinePlus Genetics' were removed from the related topics section, indicating a small site navigation/content cleanup.SummaryDifference0.1%

- Check53 days agoChange DetectedRelated topics have been expanded on the page to include Multiple sclerosis and MedlinePlus Genetics. The revision tag has been updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows a new revision label, updating from v3.6.1 to v3.6.3. This indicates an updated release of the study record, typically reflecting administrative updates or corrections.SummaryDifference0.0%

Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.